Lung volume reduction coil treatment for patients with severe emphysema: A European multicentre trial

Thorax

Volumn 69, Issue 11, 2014, Pages 980-986

  Deslee, Gaëtan ^a   Klooster, Karin ^b   Hetzel, Martin ^c   Stanzel, Franz ^d   Kessler, Romain ^e   Marquette, Charles Hugo ^f   Witt, Christian ^g   Blaas, Stefan ^h   Gesierich, Wolfgang ⁱ   Herth, Felix J F ^j   Hetzel, Juergen ^k   Van Rikxoort, Eva M ^l   Slebos, Dirk Jan ^b  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Krankenhaus vom Roten Kreuz   (Germany)

^d Lungenklinik ^*  (Germany)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f UNIVERSITY HOSPITAL OF NICE   (France)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Donaustauf Hospital   (Germany)

ⁱ Comprehensive Pneumology Center Munich   (Germany)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^l RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRONCHOSCOPY; CLINICAL TRIAL; CONTROLLED STUDY; DEVICES; EUROPE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG RESECTION; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; PULMONARY EMPHYSEMA; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; BRONCHOSCOPY; EUROPE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PNEUMONECTOMY; PROSPECTIVE STUDIES; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84922292304     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205221     Document Type: Article

References (30)

1. Shah PL, Herth FJ. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax 2014;69:280-6.
2. Gasparini S, Zuccatosta L, Bonifazi M, et al. Bronchoscopic treatment of emphysema: state of the art. Respiration 2012;84:250-63.
3. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73.
4. Criner GJ, Cordova F, Sternberg AL, et al. The NETT: part I. Lessons learned about emphysema. Am J Respir Crit Care Med 2011;184:763-70.
5. Meyers BF, Patterson GA. Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Thorax 2003;58:634-8.
6. Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010;363:1233-44.
7. Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012;39:1334-42.
8. Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J 2013;41:302-8.
9. Herth FJ, Eberhard R, Gompelmann D, et al. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010;4:225-31.
10. Slebos DJ, Klooster K, Ernst A, et al. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012;142:574-82.
11. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005;2:111-24.
12. Hartman JE, Ten Hacken NH, Klooster K, et al. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J 2012;40:1137-41.
13. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011;37:784-90.
14. Jones PW. St George's respiratory questionnaire: MCID. COPD 2005;2:75-9.
15. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
16. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005;26:153-61.
17. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
18. van Rikxoort EM, de Hoop B, Viergever MA, et al. Automatic lung segmentation from thoracic computed tomography scans using a hybrid approach with error detection. Med Phys 2009;36:2934-47.
19. Shah PL, Zoumot Z, Singh S, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013;1:233-40.
20. Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011;378:997-1005.
21. Deslee G, Barbe C, Bourdin A, et al. Cost-effectiveness of lung volume reduction coil treatment in emphysema: STIC REVOLENS. Rev Mal Respir 2012;29:1157-64.
22. Washko GR, Martinez FJ, Hoffman EA, et al. Physiological and computed tomographic predictors of outcome from lung volume reduction surgery. Am J Respir Crit Care Med 2010;181:494-500.
23. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006;119:21-31.
24. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506-12.
25. Baraldo S, Turato G, Saetta M. Pathophysiology of the small airways in chronic obstructive pulmonary disease. Respiration 2012;84:89-97.
26. Stoller JK, Gildea TR, Ries AL, et al. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency. Ann Thorac Surg 2007;83(Suppl 1):241-51.
27. Mahler DA, Faryniarz K, Tomlinson D, et al. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest 1992;102:395-401.
28. Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82:431-43.
29. Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012;39:1326-33.
30. Herth FJ, Gompelmann D, Stanzel F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal(R)). Respiration 2011;82:36-45.